Inventor · disambiguated record
Jim H. Kou
Also filed as: KOU JIM · KOU JIM H · KOU JIM HWAICHER
15 granted patents·5 pending applications·290 citations·filing 1993–2025
93Inventor score
Files withIMPAX LABORATORIES INC6SCHERING CORP5HSU ANN2TAIHO PHARMACEUTICAL CO LTD2ALANI LAMAN LYNN1
Top patents by PatentIndex Score
20 records- 0197US8377474B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2008·Granted Feb 19, 2013·48 cites·82 claims
- 0292US5470582AControlled delivery of pharmaceuticals from preformed porous polymeric microparticlesSYNTEX INC·Filed 1993·Granted Nov 28, 1995·152 cites·15 claims
- 0389US8557283B2Controlled release formulations of levodopa and uses thereofHSU ANN·Filed 2012·Granted Oct 15, 2013·9 cites·9 claims
- 0488US9089608B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Jul 28, 2015·6 cites·21 claims
- 0587US6979463B2Stable extended release oral dosage compositionSCHERING CORP·Filed 2002·Granted Dec 27, 2005·26 cites·32 claims
- 0686US9089607B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Jul 28, 2015·5 cites·56 claims
- 0784US8454998B2Controlled release formulations of levodopa and uses thereofHSU ANN·Filed 2012·Granted Jun 4, 2013·5 cites·30 claims
- 0882US9463246B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Oct 11, 2016·3 cites·54 claims
- 0979US11963971B2Combination decitabine and cedazuridine solid oral dosage formsOTSUKA PHARMA CO LTD·Filed 2023·Granted Apr 23, 2024·0 cites·9 claims
- 1072US8183287B2Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disordersKOU JIM H·Filed 2007·Granted May 22, 2012·3 cites·24 claims
- 1172US7820199B2Stable extended release oral dosage compositionSCHERING CORP·Filed 2005·Granted Oct 26, 2010·1 cites·16 claims
- 1269US12239653B2Combination decitabine and cedazuridine solid oral dosage formsTAIHO PHARMACEUTICAL CO LTD·Filed 2021·Granted Mar 4, 2025·0 cites·10 claims
- 1369US6100274A8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositionsSCHERING CORP·Filed 1999·Granted Aug 8, 2000·32 cites·40 claims
- 1466US2025177427A1Combination decitabine and cedazuridine solid oral dosage formsTAIHO PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1565US9901640B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2016·Granted Feb 27, 2018·0 cites·25 claims
- 1665US2008293734A1Pharmaceutical compositionsSCHERING CORP·Filed 2008·Application pending·0 cites
- 1761US9533046B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2015·Granted Jan 3, 2017·0 cites·31 claims
- 1850US2006009504A1Pharmaceutical compositionsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1945US2013064896A1Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic PolymerALANI LAMAN LYNN·Filed 2010·Application pending·0 cites
- 2038US2011207740A1Pharmaceutical compositionsHEIMBECHER SUSAN K·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jim H. Kou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →